Chandra Remedies Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.50 M
- Company Age 20 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 9.00 M
- Revenue Growth -70.39%
- Profit Growth -1587.63%
- Ebitda -83.65%
- Net Worth -19.78%
- Total Assets -19.84%
About Chandra Remedies
Chandra Remedies Private Limited (CRPL) is a Private Limited Indian Non-Government Company incorporated in India on 13 May 2004 and has a history of 20 years and nine months. Its registered office is in Nagpur, Maharashtra.
The Company is engaged in the Infrastructure And Utilities Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹9.00 M.
Sumit Gupta, Amit Gupta, and Dineshchandra Gupta serve as directors at the Company.
Company Details
- Location Nagpur, Maharashtra
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24230MH2004PTC146275
-
Company No.
146275
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
13 May 2004
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Chandra Remedies?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sumit Gupta
|
Director | 01-Nov-2008 | Current |
|
Amit Gupta
|
Director | 01-Nov-2008 | Current |
|
Dineshchandra Gupta
|
Director | 13-May-2004 | Current |
Financial Performance of Chandra Remedies.
Chandra Remedies Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 70.39% decrease. The company also saw a substantial fall in profitability, with a 1587.63% decrease in profit. The company's net worth observed a substantial decline by a decrease of 19.78%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Chandra Remedies?
In 2020, Chandra Remedies had a promoter holding of 66.34% and a public holding of 33.66%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹9.00 M
₹0
Charges Breakdown by Lending Institutions
- Shri Anand Nagari Sahakari Bank Limited : 0.90 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Dec 2014 | Shri Anand Nagari Sahakari Bank Limited | ₹4.50 M | Open |
| 27 Mar 2014 | Shri Anand Nagari Sahakari Bank Limited | ₹4.50 M | Open |
How Many Employees Work at Chandra Remedies?
Unlock and access historical data on people associated with Chandra Remedies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Chandra Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Chandra Remedies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
